110 related articles for article (PubMed ID: 15582431)
1. Synthesis of digalactosyl diacylglycerols and their structure-inhibitory activity on human lanosterol synthase.
Tanaka R; Sakano Y; Nagatsu A; Shibuya M; Ebizuka Y; Goda Y
Bioorg Med Chem Lett; 2005 Jan; 15(1):159-62. PubMed ID: 15582431
[TBL] [Abstract][Full Text] [Related]
2. Structure and activity relationship of monogalactosyl diacylglycerols, which selectively inhibited in vitro mammalian replicative DNA polymerase activity and human cancer cell growth.
Matsui Y; Hada T; Maeda N; Sato Y; Yamaguchi Y; Takeuchi T; Takemura M; Sugawara F; Sakaguchi K; Yoshida H; Mizushina Y
Cancer Lett; 2009 Sep; 283(1):101-7. PubMed ID: 19376642
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of human lanosterol synthase by the constituents of Colocasia esculenta (taro).
Sakano Y; Mutsuga M; Tanaka R; Suganuma H; Inakuma T; Toyoda M; Goda Y; Shibuya M; Ebizuka Y
Biol Pharm Bull; 2005 Feb; 28(2):299-304. PubMed ID: 15684488
[TBL] [Abstract][Full Text] [Related]
4. Quinuclidine inhibitors of 2,3-oxidosqualene cyclase-lanosterol synthase: optimization from lipid profiles.
Brown GR; Hollinshead DM; Stokes ES; Clarke DS; Eakin MA; Foubister AJ; Glossop SC; Griffiths D; Johnson MC; McTaggart F; Mirrlees DJ; Smith GJ; Wood R
J Med Chem; 1999 Apr; 42(7):1306-11. PubMed ID: 10197973
[TBL] [Abstract][Full Text] [Related]
5. Farnesyloxycoumarins, a new class of squalene-hopene cyclase inhibitors.
Cravotto G; Balliano G; Robaldo B; Oliaro-Bosso S; Chimichi S; Boccalini M
Bioorg Med Chem Lett; 2004 Apr; 14(8):1931-4. PubMed ID: 15050630
[TBL] [Abstract][Full Text] [Related]
6. Novel pyrrole- and 1,2,3-triazole-based 2,3-oxidosqualene cyclase inhibitors.
Watanabe T; Umezawa Y; Takahashi Y; Akamatsu Y
Bioorg Med Chem Lett; 2010 Oct; 20(19):5807-10. PubMed ID: 20728352
[TBL] [Abstract][Full Text] [Related]
7. Inhibitors of UDP-galactopyranose mutase thwart mycobacterial growth.
Dykhuizen EC; May JF; Tongpenyai A; Kiessling LL
J Am Chem Soc; 2008 May; 130(21):6706-7. PubMed ID: 18447352
[TBL] [Abstract][Full Text] [Related]
8. 29-Methylidene-2,3-oxidosqualene derivatives as stereospecific mechanism-based inhibitors of liver and yeast oxidosqualene cyclase.
Ceruti M; Rocco F; Viola F; Balliano G; Milla P; Arpicco S; Cattel L
J Med Chem; 1998 Feb; 41(4):540-54. PubMed ID: 9484504
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis, and biological evaluation of new (2E,6E)-10-(dimethylamino)-3,7-dimethyl-2,6-decadien-1-ol ethers as inhibitors of human and Trypanosoma cruzi oxidosqualene cyclase.
Galli U; Oliaro-Bosso S; Taramino S; Venegoni S; Pastore E; Tron GC; Balliano G; Viola F; Sorba G
Bioorg Med Chem Lett; 2007 Jan; 17(1):220-4. PubMed ID: 17027267
[TBL] [Abstract][Full Text] [Related]
10. Revised structures of epohelmins A and B isolated as lanosterol synthase inhibitors from a fungal strain FKI-0929.
Shibuya M; Snider BB; Sakano Y; Tomoda H; Omura S; Ebizuka Y
J Antibiot (Tokyo); 2005 Sep; 58(9):599-601. PubMed ID: 16320765
[TBL] [Abstract][Full Text] [Related]
11. Selective in vivo anti-inflammatory action of the galactolipid monogalactosyldiacylglycerol.
Bruno A; Rossi C; Marcolongo G; Di Lena A; Venzo A; Berrie CP; Corda D
Eur J Pharmacol; 2005 Nov; 524(1-3):159-68. PubMed ID: 16253232
[TBL] [Abstract][Full Text] [Related]
12. Insight Mechanism of the Selective Lanosterol Synthase Inhibitor: Molecular Modeling, Docking and Density Functional Theory Approaches.
Karunagaran S; Kavitha R; Vadivelu M; Lee KW; Meganathan C
Curr Comput Aided Drug Des; 2017 Nov; 13(4):275-293. PubMed ID: 28462697
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of novel ammonium and selenonium ions and their evaluation as inhibitors of UDP-galactopyranose mutase.
Veerapen N; Yuan Y; Sanders DA; Pinto BM
Carbohydr Res; 2004 Sep; 339(13):2205-17. PubMed ID: 15337448
[TBL] [Abstract][Full Text] [Related]
14. GRIND-based 3D-QSAR to predict inhibitory activity for similar enzymes, OSC and SHC.
Ermondi G; Caron G
Eur J Med Chem; 2008 Jul; 43(7):1462-8. PubMed ID: 17981368
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis and evaluation of potent thymidylate synthase X inhibitors.
Esra Onen F; Boum Y; Jacquement C; Spanedda MV; Jaber N; Scherman D; Myllykallio H; Herscovici J
Bioorg Med Chem Lett; 2008 Jun; 18(12):3628-31. PubMed ID: 18513963
[TBL] [Abstract][Full Text] [Related]
16. Novel 4-piperidinopyridine inhibitors of oxidosqualene cyclase-lanosterol synthase derived by consideration of inhibitor pK(a).
Brown GR; Foubister AJ; Johnson MC; Newcombe NJ; Waterson D; Wells SL
Bioorg Med Chem Lett; 2001 Aug; 11(16):2213-6. PubMed ID: 11514173
[TBL] [Abstract][Full Text] [Related]
17. 1-(2-Carboxyindol-5-yloxy)propan-2-ones as inhibitors of human cytosolic phospholipase A2alpha: synthesis, biological activity, metabolic stability, and solubility.
Fritsche A; Elfringhoff AS; Fabian J; Lehr M
Bioorg Med Chem; 2008 Apr; 16(7):3489-500. PubMed ID: 18321717
[TBL] [Abstract][Full Text] [Related]
18. In vitro anti-denaturation and anti-hyaluronidase activities of extracts and galactolipids from leaves of Impatiens parviflora DC.
Grabowska K; Podolak I; Galanty A; Załuski D; Makowska-Wąs J; Sobolewska D; Janeczko Z; Żmudzki P
Nat Prod Res; 2016; 30(10):1219-23. PubMed ID: 26181315
[TBL] [Abstract][Full Text] [Related]
19. Umbelliferone aminoalkyl derivatives as inhibitors of human oxidosqualene-lanosterol cyclase.
Oliaro-Bosso S; Taramino S; Viola F; Tagliapietra S; Ermondi G; Cravotto G; Balliano G
J Enzyme Inhib Med Chem; 2009 Apr; 24(2):589-98. PubMed ID: 18830877
[TBL] [Abstract][Full Text] [Related]
20. Insight into steroid scaffold formation from the structure of human oxidosqualene cyclase.
Thoma R; Schulz-Gasch T; D'Arcy B; Benz J; Aebi J; Dehmlow H; Hennig M; Stihle M; Ruf A
Nature; 2004 Nov; 432(7013):118-22. PubMed ID: 15525992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
